Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia
Malaysia Stop Tyrosine Kinase Inhibitor Trial
Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response
|5||Not yet recruiting||
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission
† Study has passed its completion date and status has not been verified in more than two years.